Wegovy is indicated for people ages 12 years and older who have: A BMI of 30 kg/m 2 or higher A BMI of 27 kg/m 2 to 29.9 kg/m 2 and at least one weight-related comorbidity , such as high blood pressure, type 2 diabetes, or obstructive sleep apnea Wegovy is also indicated to reduce the risk of major cardiovascular events , such as heart attack or stroke, in people who have obesity or overweight
Examples: olive and flax oils, avocados, nuts and seeds, fatty fish
increased slightly between 2021 and 2024, but their uptake remained limited, with *ONLY 3%* of eligible patients having ever received a prescription during that period." "Low adoption and disparities in use likely reflect both system-level access barriers and patient-level demand, including narrow eligibility, limited insurance coverage, and financial considerations that may lead some individuals to forgo treatment after prescription." *NOTE: "did not include prescriptions from online-only pharmacies" and "products for diabetes were excluded" #obesity #medication #treatment #GLP1 #semaglutide #tirzepatide Sean C
Leatherhead: electronic Medicines Compendium
It has also been shown to reduce waist circumference, curb unhealthy cravings, and extend the patients sense of fullness after eating
